Carlos Ramirez represents private and public companies in corporate and securities matters, including private financings, public offerings, M&A, corporate governance matters, and Securities and Exchange Commission reporting and compliance. He also advises venture capital and private equity funds and investment banking firms in connection with financings.

Download full bio 


  • The Honest Company – $475 Million IPO 

  • Metacrine – $85 Million IPO 

  • Neurocrine Partners With Takeda to Address Psychiatric Disorders 

  • Vir Biotechnology - $143 Million IPO 

  • Novo Holdings Leads $72 Million Series E for LanzaTech 

  • View all


  • Northwestern University School of Law
    JD, 2013

  • Loyola Marymount University
    BBA, Business Law

  • Loyola Marymount University
    BSA, Accounting

Admissions & Credentials



  • American Bar Association

  • San Diego County Bar Association

  • Hispanic National Bar Association

Rankings & Accolades

    Hispanic National Bar Association: Top Lawyers Under 40